A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Clinical trial NCT02614794 · COMPLETED
Trial details
- NCT number
- NCT02614794
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-28
- Primary completion
- 2019-09-04
- Enrollment
- 612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.